EUVIMEDDescoperă EUVIMED
VergleichsstudieOpen access · CC BY-NC-ND 4.0

Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study

Margot Sauvee, Emelyne Lefizelier, Louen Ropers, Jerome Dimet, Guillaume Ducarme iD

Acta Obstetricia et Gynecologica Scandinavica · 2026-05 · 105 (5) · 940-947

DOI: 10.1111/aogs.70180 ↗

At a glance

Vergleichsstudie in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-02-24. Written by Margot Sauvee and 4 co-authors. Institution: Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, La Roche sur Yon, France. Major MEDLINE topics: Postpartum Hemorrhage, Oxytocin, Delivery, Obstetric, Oxytocics. 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Introduction Data with a high level of evidence is lacking on the use of prophylactic uterotonic drug following vaginal delivery to prevent postpartum hemorrhage (PPH) among women who were considered high‐risk for PPH. Our main objective was to compare the effectiveness of prophylactic carbetocin versus oxytocin in preventing PPH after vaginal delivery among women at high risk. Material and Methods We conducted a retrospective before‐and‐after single‐center comparative study, including all high‐risk women after vaginal births. Two consecutive 14‐month periods were compared, where the prophylactic methods to prevent PPH differed: oxytocin (5 IU IV) versus carbetocin (100 μg IV) given immediately after vaginal delivery. High‐risk women were defined by at least one of the following criteria: previous PPH (blood loss ≥500 mL), antenatal suspicion of macrosomia (estimated fetal weight >90th p), twin pregnancy, repeated cervical ripening methods, polyhydramnios, multiparity (≥4), and rapid labor (

Subjects

MeSH terms (MEDLINE)

Postpartum HemorrhageOxytocinDelivery, ObstetricOxytocicsVaginaRetrospective StudiesTreatment OutcomeHumansFemalePregnancyAdult

Author keywords

carbetocinoxytocinpostpartum hemorrhagepreventionvaginal delivery

Substances

carbetocinOxytocinOxytocics

Authors and institutions

  • Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, La Roche sur Yon, France.
  • Clinical Research Center, Centre Hospitalier Departemental, La Roche sur Yon, France.

ORCID profiles: Guillaume Ducarme

Cite

APA

Sauvee, M., Lefizelier, E., Ropers, L., Dimet, J., & Ducarme, G. (2026). Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study. Acta Obstetricia et Gynecologica Scandinavica, 105(5), 940-947. https://doi.org/10.1111/aogs.70180

Vancouver

Sauvee M, Lefizelier E, Ropers L, Dimet J, Ducarme G. Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(5):940-947. doi:10.1111/aogs.70180

BibTeX
@article{Sauvee2026,
  author = {Sauvee, Margot and Lefizelier, Emelyne and Ropers, Louen and Dimet, Jerome and Ducarme, Guillaume},
  title = {Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  volume = {105},
  number = {5},
  pages = {940--947},
  doi = {10.1111/aogs.70180}
}
Start for free →